Yuhan Corp - Company Profile

Powered by

All the sales intelligence you need on Yuhan Corp in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Yuhan Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Yuhan Corp.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Yuhan Corp patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4055014A4 Search Report Pyrrolidin- und piperidinverbindungen A61K31/4025; A61K31/423; A61K31/4355; A61K31/4365; A61K31/4545; A61K31/4709; A61K31/4725; A61K31/517; A61K31/519; A61K31/5377; A61P1/16; A61P35/00; C07D207/16; C07D401/14; C07D403/06; C07D403/14; C07D405/14; C07D409/14; C07D413/14; C07D417/14; C07D471/04; C07D491/048; C07D495/04 December 06, 2023
WO2023229441A1 Application Combined administration pharmaceutical composition comprising, as active ingredient for prevention or treatment of cancer, enzymatic degradation extract of deer antler enhancing activity of immune cells including nk cells and immunotherapeutic anticancer agent November 30, 2023
EP3866767B1 Grant Pharmazeutische zusammensetzung zum einnehmen mit aminopyrimidinderivat oder salz davon A61K31/5377; A61K9/0053; A61K9/2013; A61K9/2018; A61K9/2027; A61K9/2054; A61K9/2059 November 29, 2023
EP3521831B1 Grant Vorrichtung zur verarbeitung biologischer proben B01L2300/0672; B01L2300/0829; B01L3/0237; B01L3/0293; B01L7/00; G01N2035/00178; G01N2035/00277; G01N2035/00287; G01N2035/00346; G01N2035/00425; G01N2035/0401; G01N2035/0474; G01N2035/0477; G01N2035/106; G01N35/00; G01N35/0098; G01N35/02; G01N35/026; G01N35/028; G01N35/04; G01N35/10; G01N35/1065; G01N35/1074; G01N35/1079; G01N35/1081; G01N35/109 November 29, 2023
ZA202200905B Grant Anti-egfr/anti-4-1bb bispecific antibody and use thereof A61K2039/505; A61K39/39541; A61P35/00; A61P37/04; C07K16/2863; C07K16/2878; C07K2317/21; C07K2317/24; C07K2317/31; C07K2317/565; C07K2317/622; C07K2317/64; C07K2317/71; C07K2317/73; C07K2317/732; C07K2317/75; C07K2317/76; C07K2317/92 November 29, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer